Venrock

AI voice tech startup Suki partners with Google Cloud | Healthcare Dive | 10/30/2019

Healthcare Dive, and expects that to triple or even quadruple by January. The tech is deployed in Ascension, OB-GYN practice giant Unified and 60 to 70 mid- to small-size practices. Two “very, very large deployment announcements” with major U.S. health systems are expected to be announced in the next month or so, Soni said. Dive Insight: Voice-enabled technologies that allow physicians free use of their hands and …

Bellerophon Therapeutics Inc (NASDAQ:BLPH) Major Shareholder Sells $352,297.50 in Stock | 10/29/2019

Bellerophon Therapeutics Inc (NASDAQ:BLPH) major shareholder Associates Iv L. P. Venrock sold 704,595 shares of the company’s stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $0.50, for a total value of $352,297.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website . Large shareholders that own more than 10% of …

Follow Venrock:    

Insider Selling: Bellerophon Therapeutics Inc (NASDAQ:BLPH) Major Shareholder Sells 333,010 Shares of Stock | 10/29/2019

Bellerophon Therapeutics Inc (NASDAQ:BLPH) major shareholder Associates Iv L. P. Venrock sold 333,010 shares of the firm’s stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $0.44, for a total value of $146,524.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website . Large shareholders that own at least 10 …

Bellerophon Therapeutics Inc (NASDAQ:BLPH) Major Shareholder Associates Iv L. P. Venrock Sells 333,010 Shares | 10/29/2019

Bellerophon Therapeutics Inc (NASDAQ:BLPH) major shareholder Associates Iv L. P. Venrock sold 333,010 shares of the business’s stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $0.44, for a total transaction of $146,524.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink . Large shareholders that own 10% or more …

Bellerophon Therapeutics Inc (NASDAQ:BLPH) Major Shareholder Associates Iv L. P. Venrock Sells 704,595 Shares - TheOlympiaReport | 10/29/2019

Bellerophon Therapeutics Inc (NASDAQ:BLPH) major shareholder Associates Iv L. P. Venrock sold 704,595 shares of the stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $0.50, for a total value of $352,297.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink . Large shareholders that own more than 10% of …

Wholesale Commerce Platform Company Mable Secures $3 Million In Funding | 10/23/2019

Mable, a Boston-based wholesale commerce platform company, announced recently that it raised $3.1 million in a seed round of funding Boston-based company Mable announced recently that it raised $3.1 million in a seed round of funding to launch a wholesale commerce platform for small businesses in the grocery, convenience, artisanal, and health food market spaces. Venrock, Accomplice, and Founder Collective led the funding round along with several angel …

Dafina Toncheva Gets Promoted To General Partner At U.S. Venture Partners | 10/16/2019

Silicon Valley venture capital firm U.S. Venture Partners announced it promoted Dafina Toncheva to General Partner. These are the details. Silicon Valley venture capital firm U.S. Venture Partners recently announced that it promoted Dafina Toncheva to General Partner. Toncheva had joined USVP in November 2012 after she spent several years in high-technology operating roles and experience at companies like Microsoft, Bain, and Venrock. Toncheva invests in emerging technologies in …

Cyteir Therapeutics scores $40.2 mln Series B | PE Hub | 10/15/2019

Cyteir Therapeutics scores $40.2 mln Series B October 15, 2019 By Iris Dorbian Lexington, Massachusetts-based Cyteir Therapeutics , a developer of next-generation synthetic lethal therapies for cancer, has secured $40.2 million in Series B funding. Novo Holdings led the round with participation from Venrock, DROIA Oncology Ventures, Osage University Partners, Lightstone Ventures and Celgene Corporation . As part of this closing, Dr. Karen Hong of Novo Ventures will join the …

Cyteir Therapeutics Secures Additional $40.2 Million in Its Series B Financing and Doses First Patient in Phase 1/2 Study of First-in-Class RAD51 Inhibitor | PR Newswire | 10/15/2019

LEXINGTON, Mass. , Oct. 15, Cyteir Therapeutics , a leader in the discovery and development of next-generation synthetic lethal therapies for cancer, today announced the close of an additional $40.2 million in the company’s Series B financing, for a total of $75.2 million in this financing. The additional funding will be used to expand the clinical investigation of Cyteir’s first-in-class RAD51 inhibitor and lead compound, CYT-0851, and to …

Mable Raises $3MM Seed Round Led by Three Top VC Firms to Build B2B E-commerce Platform for Independent Grocers; Launches Beta | PR Newswire | 10/15/2019

BOSTON , Oct. 15, Boston-based startup Mable ( https://meetmable.com/ ) announces a $3.1 million seed round to launch a wholesale commerce platform for small businesses in the grocery, convenience, artisanal, and health food market spaces. Venrock, Accomplice, and Founder Collective led the round, along with a handful of notable angel investors including Laurent Amouyal , co-founder of Shopkeep David Olk, and James McCann . Continue Reading Mable is a simple wholesale platform …

Term Sheet: Oct. 14, 2019 | 10/14/2019

… Bulgaria to the United States in 1998 on a full scholarship to Harvard University. From there, she worked at Microsoft as a software engineer, went on to get an MBA from Stanford, and joined Venrock in her first job in venture capital. She became the first institutional investor in Cloudflare, a San Francisco-based network performance and cybersecurity firm that just went public. Toncheva has spent the last seven years …

CB Insights releases Digital Health 150 list of ‘most promising’ private startups | MobiHealthNews | 10/2/2019

… in the digital health realm. Here, the analysts identified F-Prime Capital as the most frequent investor in leading digital health companies (31 deals), followed sequentially by New Enterprise Associates (30), Google Ventures (29), Venrock (28) Founders Fund (27), Khosla Ventures (27) and GE Ventures (22). And although the 150 included startups appear to run the gamut of focus areas and audiences, the report shone a spotlight on seven trends …

WeWork Tries to Address Investor Concerns With Big Governance Changes: Term Sheet | Fortune | 9/13/2019

Let’s talk initial public offerings. WEWORK’S AMENDMENTS: WeWork is reportedly planning “sweeping” governance changes that would assuage investor concerns as it pushes ahead with its listing on Nasdaq. One, it plans to curb the voting power of co-founder Adam Neumann in order to get its upcoming IPO back on track. The company will change its high-vote stock from 20 votes to 10 votes a share to cut back …

Secretive Defense Tech Startup Anduril Reaches Unicorn Status: Term Sheet | Fortune | 9/12/2019

… is a company that aims to apply data and technology to the old-school industry of supply chain and logistics management. He and co-founder Andrea Aranguren have raised $10 million in funding from Venrock and Rucker Park. This is O’Kelley’s third startup. Before AppNexus, he sold his first company Right Media for $680 million to Yahoo in 2007. Read O’Kelley’s post about his new venture here. REMEMBERING T. BOONE …

Simbe Raises $26M Series A Led by Venrock in Addition to Substantial Inventory Financing From SoftBank Robotics | 9/12/2019

News Feed Item Simbe Raises $26M Series A Led by Venrock in Addition to Substantial Inventory Financing From SoftBank Robotics September 12, 2019 09:01 AM EDT Blog This Simbe Robotics, Inc., the company leveraging robotics and AI to provide physical retail with unparalleled insights into inventory and operations, today announced two separate funding deals – a Series A equity financing round and an inventory financing agreement with SoftBank Robotics, allowing the …

Exclusive: From CryptoKitties to Cardi B: Warner Music Joins $11 Million Investment In Ethereum Replacement | Forbes | 9/12/2019

… for other digital assets, could be adapted to create unique, tradable merchandise featuring the company’s roster of superstar talent. So as part of the investment from Andreessen Horowitz, Digital Currency Group, Union Square Ventures, Venrock and others, Bronikowski says Warner Music’s blockchain team will work with Dapper Labs to create digital assets using a new public blockchain revealed today, called Flow, that is capable of handling transaction volumes many times …

Pharvaris debuts with $66M to push oral HAE drug through the clinic | FierceBiotech | 9/10/2019

There are various treatments for hereditary angioedema (HAE), which can cause life-threatening swelling of the airways or intestinal tract, but all of them are given by injection or intravenous infusion. Pharvaris is looking to change that—the Dutch company raised $66 million in series B financing to ramp up the clinical development of an oral drug for the rare disease. Pharvaris drew the capital from a marquee group of …

Five Ways The Forbes Under 30 Summit Startup Showcase Expanded Into The Best Startup Competition Ever | 9/10/2019

Startup showcases are a key part of most entrepreneur-centric summits—a chance for founders to show off their ideas, and potential investors, partners and team members to learn about them. Given that we’ve slowly built the Forbes Under 30 Summit into the world’s top gathering for young entrepreneurs and game-changers, we’ve spent a lot of time rethinking how the showcase can be more than just booths and prospects …

Misty II begins shipping to crowdfunding backers | VentureBeat | 9/4/2019

GamesBeat Summit 2020 April 28-29, 2020 In June 2017, shortly after Misty Robotics spun out of Boulder, Colorado-based startup Sphero , it announced intentions to develop a “mainstream” home robot with the help of hobbyists and enthusiasts the world over. With $11.5 million in venture capital from Venrock and Foundry Group in the bank, it wasted no time in getting to work, unveiling a development platform called Misty I at …

Even VC’s Struggle To Find Abstract Unicorns | Forbes | 8/28/2019

A while ago, I attended the annual Churchill Club meeting in Santa Clara courtesy of Forbes for the top 10 tech trends . It’s a very cool event, and it throws light on the immensely difficult task a VC has to find abstract winners to invest in. Five VC’s: Brian Ascher of Venrock, Navin Chaddha of Mayfield, Jeff Crowe of Norwest Venture Partners, Lauren Kolodny of Aspect Ventures, and Rebecca Lynn …

Biotech

Top 10 San Francisco Bay Area Biotechs by Venture Capital Funding - BioSpace | 10/30/2019

Top 10 San Francisco Bay Area Biotechs by Venture Capital Funding Published: Oct 30, 2019 By Mark Terry Earlier this year, Crunchbase, a database that tracks startup companies and their investors, noted that biotech venture … of the company’s investors, along with Arch Venture Partners and Venrock. The $104 million raise in June 2019 brought the company’s total funding to $158 million. The company is a precision medicine firm focused on …

Vice Buys Refinery29 As the Great Digital Media Consolidation Continues: Term Sheet | Fortune | 10/3/2019

… artificial intelligence, machine learning and – computer vision firm, raised Series B funding of an undisclosed amount. Investors include Lupa Systems, Venrock and Valor Equity Partners. HEALTH & LIFE SCIENCES DEALS – Tenaya Therapeutics, Inc , a San Francisco … terms weren’t disclosed. IPOs – ADC Therapeutics SA , a Switzerland-based biotech focused on antibody therapies for cancer, withdrew its $150 million IPO. It posted revenue of $1.1 million and losses of $123.1 million in 2018 …

Health Tech

AI voice tech startup Suki partners with Google Cloud | Healthcare Dive | 10/30/2019

… almost two additional hours on paperwork. Providers spend more than half of their workday on EHR and computer tasks. The startup was founded by Soni and is backed by funding from investors like Venrock, First Round and Social Capital. The company recently raised $20 million to advance the technology in a Series A round led by Venrock. It wasn’t an outlier. Robin Healthcare, another voice-enabled clinician workflow tool, raised …

HITAC wrestles with foundational questions - POLITICO | 4/26/2019

… to clarify that it should fall to health IT groups to “include a field” for the specified data elements. SHOULD HEALTH TECH COMPANIES BRACE FOR AN ANTITRUST CRACKDOWN? —The Federal Trade Commission’s antitrust lawsuit against … I am feeling happy that [S]urescripts is getting scrutiny,” Venrock venture capitalist Bob Kocher says. One industry executive wondered if FTC might next go after the “EHR duopoly”: Epic and Cerner. But Doug Litvack …

Medicare

The mad rush to sell private Medicare plans to seniors | 10/11/2019

The mad rush to sell private Medicare plans to seniors Written By: Bloomberg Oct 10th 2019 - 7pm. Medicare Advantage plans are rushing to sign up customers after new regulations allow them to offer more non … 20 years,” said Bob Kocher, a partner at venture firm Venrock. The firm backed Devoted Health and Kocher served as the company’s chief medical officer for a year. “There should be a lot of pent …

Medicare Advantage

The mad rush to sell private Medicare plans to seniors | 10/11/2019

The mad rush to sell private Medicare plans to seniors Written By: Bloomberg Oct 10th 2019 - 7pm. Medicare Advantage plans are rushing to sign up customers after new regulations allow them to offer more non … 20 years,” said Bob Kocher, a partner at venture firm Venrock. The firm backed Devoted Health and Kocher served as the company’s chief medical officer for a year. “There should be a lot of pent …

Digital Health

CB Insights releases Digital Health 150 list of ‘most promising’ private startups | MobiHealthNews | 10/2/2019

… Selected from a pool of 5,000 companies, the full cohort paints a picture of the trends, regions and investors headlining digital health. CB Insights releases Digital Health 150 list of ‘most promising’ private startups Share … followed sequentially by New Enterprise Associates (30), Google Ventures (29), Venrock (28) Founders Fund (27), Khosla Ventures (27) and GE Ventures (22). And although the 150 included startups appear to run the gamut of focus …

Depressive Disorders Pipeline Review 2010-2019: 50% of Treated Patients do not Respond to the First Prescribed Antidepressant | PR Newswire | 6/27/2019

… drugs considered for studying the strategies in detail. Chapter 12 is a case study providing an overview on the advancing digital health solutions for the self-management and treatment of depressive disorders. Further, the chapter … of Michigan University of Oxford University of Toronto VANDA Pharmaceuticals Venrock VistaGen Therapeutics Wellcome Trust WestRiver Group Worldwide Clinical Trials Yungjin Pharmaceuticals e-therapeutics myStrength For more information about this report visit https://www.researchandmarkets.com/r …

ACO

Misty Robotics Selects Microsoft’s .NET Core for Its Robot Platform and Tools | Business Wire | 5/6/2019

… will offer the robot maker the latest tooling from Microsoft as well as cross-platform compatibility including support of Windows, macOS, and Linux. The open-source, general-purpose development platform maintained by Microsoft and the … Based in Boulder, Colorado, the company is financially backed by Venrock, Foundry Group and others. Contacts …

CRISPR

Brainstorm Health: Free CRISPR Enzyme, Doug Jones and CHIP, Novartis Generics Unit | Fortune | 12/14/2017

10:34 AM EST Good morning, readers! This is Sy. CRISPR gene editing is widely regarded as one of the most significant advances in the life sciences in decades. The technology, which allows scientists to slice … factions’ various affiliated biotechs). Well, Inscripta, a startup backed by Venrock, wants to take the IP considerations out of the equation by providing a new kind of CRISPR enzyme to (most) scientists at no cost …

This Startup Has a New CRISPR Enzyme - And Says It Will Give It Away For Free | Forbes | 12/13/2017

Dec 13, 2017 @ 06:00 AM This Startup Has a New CRISPR Enzyme – And Says It Will Give It Away For Free I cover science and medicine, and believe this is biology’s century. Shutterstock A startup … a high-school dropout,” says Bryan Roberts, venture capitalist at Venrock. “That is not the way that CRISPR-gene-editing is today.” Venrock led a $23 million fundraising round for Inscripta in February. Another business …

Apple Health

AI voice tech startup Suki partners with Google Cloud | Healthcare Dive | 10/30/2019

… workday on EHR and computer tasks. The startup was founded by Soni and is backed by funding from investors like Venrock, First Round and Social Capital. The company recently raised $20 million to advance the … announced it was partnering with Notable, a platform supported by Apple Watch that documents physician-patient interactions and uses machine learning. Also this month, tech giant Microsoft announced a partnership with clinical documentation company Nuance …

Sprout, The Company Focused on Women’s Sexual Pleasure, Raises $20 Million: Term Sheet | Fortune | 9/4/2019

… Partners, Product Co-Op, and SOSC. – RocketBody , a Delaware-based maker of an ECG-based personal trainer app for the Apple Watch, raised $1 million in funding from Gagarin Capital. HEALTH & LIFE SCIENCES DEALS – M2i … billion and earnings of $237.7 million in 2018. Foresite Capital, Venrock, Paladin Capital , and Fidelity back the firm. It plans to list on the NYSE as “NVST.” Read more . – Vir Biotechnology , a San Francisco-based …

OrbiMed

Term Sheet: Oct. 16, 2019 | 10/16/2019

… the round. - Mable , a Boston-based startup mobile and web-based B2B wholesale platform, raised $3.1 million in seed funding. Venrock, Accomplice, and Founder Collective led the round. - Hummingbird Technologies , a London-based tech platform … of $8.3 million in 2018 and loss of $29.9 million. OrbiMed (34.6% pre-offering), Quaker BioVentures (21.2%), and Pacira Pharmaceuticals (13.6%) back the firm. It plans to list on the Nasdaq as “TELA.” Read more …

WeWork Tries to Address Investor Concerns With Big Governance Changes: Term Sheet | Fortune | 9/13/2019

… has raised more than $332 million in total venture capital funding since its inception. Its largest outside backers include Fidelity, Venrock, NEA, and Pelion Ventures. The company was last valued at $3.2 billion in the … posted a loss of $17.8 million in 2018. Pfizer, Bain, OrbiMed , and Perceptive Life Sciences back the firm. It plans to list on the Nasdaq as “SWTX.” Read more . – Satsuma Pharmaceuticals , a South San Francisco …

Celgene

Cyteir Therapeutics scores $40.2 mln Series B | PE Hub | 10/15/2019

Cyteir Therapeutics scores $40.2 mln Series B October 15, 2019 By Iris Dorbian Lexington, Massachusetts-based Cyteir Therapeutics , a developer of next-generation synthetic lethal therapies for cancer, has secured $40.2 million in Series B funding. Novo Holdings led the round with participation from Venrock, DROIA Oncology Ventures, Osage University Partners, Lightstone Ventures and Celgene Corporation . As part of this closing, Dr. Karen Hong of Novo Ventures will join the …

Cyteir Therapeutics Secures Additional $40.2 Million in Its Series B Financing and Doses First Patient in Phase 1/2 Study of First-in-Class RAD51 Inhibitor | PR Newswire | 10/15/2019

… Venrock, DROIA Oncology Ventures, Osage University Partners (OUP), Lightstone Ventures and Celgene Corporation. As part of this closing, Karen Hong , Ph.D., of Novo Ventures, which provides consulting services to Novo Holdings, will join the Cyteir Board. “The continued support for Cyteir from highly knowledgeable investors reflects the growing excitement around our novel application of synthetic lethality,” said Markus Renschler , M.D., Cyteir president and CEO. “This financing will support the recently …

Pfizer

WeWork Tries to Address Investor Concerns With Big Governance Changes: Term Sheet | Fortune | 9/13/2019

… has raised more than $332 million in total venture capital funding since its inception. Its largest outside backers include Fidelity, Venrock, NEA, and Pelion Ventures. The company was last valued at $3.2 billion in the … revenue and posted a loss of $17.8 million in 2018. Pfizer, Bain, OrbiMed , and Perceptive Life Sciences back the firm. It plans to list on the Nasdaq as “SWTX.” Read more . – Satsuma Pharmaceuticals , a South …

RefleXion Highlights Novel Approach to Radiotherapy at ASTRO 2019 | Globe Newswire | 9/12/2019

… Venrock, T. Rowe Price Associates, Inc., China-focused healthcare investment firm GT Healthcare Capital Partners, Oxford Capital and global pharmaceutical leaders Pfizer Venture Investments and Johnson & Johnson Innovation, JJDC Inc. UPMC holds a passive, minority investment in RefleXion, and Dr. Jason Luke is a paid consultant for RefleXion. The RefleXion Machine requires 510(k) clearance and is not yet commercially available in the United States. A photo accompanying this announcement …

Novartis

Secretive Defense Tech Startup Anduril Reaches Unicorn Status: Term Sheet | Fortune | 9/12/2019

… industry of supply chain and logistics management. He and co-founder Andrea Aranguren have raised $10 million in funding from Venrock and Rucker Park. This is O’Kelley’s third startup. Before AppNexus, he sold his first … company, raised $40 million in funding. Investors include Versant Ventures, Novartis Venture Fund, Novo Ventures and Celgene . Financial terms weren’t disclosed. PRIVATE EQUITY DEALS – High Street Insurance Partners , which is backed by Huron Capital , acquired …

Sprout, The Company Focused on Women’s Sexual Pleasure, Raises $20 Million: Term Sheet | Fortune | 9/4/2019

… in an initial public offering. It posted revenue of $2.8 billion and earnings of $237.7 million in 2018. Foresite Capital, Venrock, Paladin Capital , and Fidelity back the firm. It plans to list on the NYSE … Investments, MPM Capital, F-Prime Capital Partners, ARCH Venture Partners, Novartis, Medtronic, JDRF T1D Fund, ORI Healthcare Fund, Wu Capital, 6 Dimensions Capital and SinoPharm Capital. FIRMS + FUNDS – Freeman Spogli & Co, a Los Angeles-based …

GSK

Salsify and Geometry Partner to Provide PXM Capabilities To the World’s Global Brands | PR Newswire | 6/18/2019

GSK, Rawlings, and Fruit of the Loom use Salsify every day to stand out on the digital shelf. To date, Salsify has raised a total of $98.1 million in funding, led by Greenspring Associates, Underscore VC, Venrock, Matrix Partners and North Bridge. For more information, please visit: http://www.salsify.com About Geometry Geometry is the WPP end-to-end Commerce agency, operating in 56 markets around the world and conceived to …

IPO Update: Milestone Pharmaceuticals Readies $75 Million IPO - Milestone Pharmaceuticals (Pending:MIST) | Seeking Alpha | 5/1/2019

… solidarité FTQ, Pappas Capital, Tekla Capital Management, BDC Capital Corporation, Forbion Capital Partners, Boxer Capital, Domain Associates, GO Capital, and Venrock Healthcare Partners, among others. Source: VentureDeal Venture Capital Database Market & Competition According to a … Major competitors that provide or are developing treatments include: GlaxoSmithKline ( GSK ) Novartis ( NVS ) Pfizer ( PFE ) AstraZeneca ( AZN ) Teva Pharmaceutical Industries ( TEVA ) Sanofi ( SNY ) Medtronic ( MDT ) Glenmark Pharmaceuticals (GLENMARK.NS) Source: Sentieo According to management, the company’s …

Theranos

How to avoid funding the next Theranos: Guidelines for healthcare VCs - Business Insider | 6/14/2019

Healthcare investing often has greater scientific complexity than standard tech venture capital. Theranos is a well-known example of a risky healthcare bet gone wrong, but some experts say other problematic startups are on the … is a vice president at the Silicon Valley venture firm Venrock Dan Estes is a partner at Frazier Healthcare Partners John Ioannidis is a professor of medicine at Stanford who was an early Theranos whistleblower …

Health and science startups could be uniquely positioned to dupe investors and the public, experts say | Business Insider | 6/8/2019

Elizabeth Holmes, the founder and CEO of Theranos, at the 2015 Wall Street Journal Digital Live conference in Laguna Beach, California. Mike Blake/Reuters Health and science startups seem uniquely positioned to fool investors and … need, Racquel Bracken , a vice president at the venture firm Venrock, told Business Insider. Read more: As Silicon Valley tech giants like Facebook and Juul push into healthcare, they see revolution. Outside experts see red …

ARCH Venture Partners

Top 10 San Francisco Bay Area Biotechs by Venture Capital Funding - BioSpace | 10/30/2019

… Arch Venture Partners and Venrock. The $104 million raise in June 2019 brought the company’s total funding to $158 million. The company is a precision medicine firm focused on tests for a gene therapy for a rare type of epilepsy known as Dravet syndrome. 6. Apollomics. $100 million. Apollomics is an oncology company with a particular focus on combination therapies. It has a pipeline of six development-stage assets including …

Sprout, The Company Focused on Women’s Sexual Pleasure, Raises $20 Million: Term Sheet | Fortune | 9/4/2019

… Venrock, Paladin Capital , and Fidelity back the firm. It plans to list on the NYSE as “NVST.” Read more . – Vir Biotechnology , a San Francisco-based biotech focused on immunologic therapies for infectious diseases, plans to raise $100 million in an initial public offering. It posted revenue of $10.7 million and a loss of $115.9 million in 2018. ARCH Venture Partners and SoftBank back the firm. It plans to list on …

New Enterprise Associates

Is Compact Fusion Power Now Fewer Than 15 Years Away — I Think So | 10/14/2019

New Enterprise Associates (NEA), Venrock, and Wellcome Trust. The company has successfully raised over $500 million and has been in operation for over 20 years. TAE is developing a (challenging) aneutronic design that, if it works, will largely remove neutron radiation and produce an electric current as the direct product of a hydrogen-boron fusion reaction. TAE states, “The proprietary beam-driven FRC approach utilizes injection of beams of high …

Leading Gig Platforms put Stride’s New Benefits Platform to Work | PR Newswire | 8/21/2019

… Venrock, New Enterprise Associates and F-Prime Capital Partners. About DoorDash: Doordash is a technology platform that connects customers with their favorite local and national businesses in over 4,000 cities and all 50 states across the United States and Canada . Founded in 2013 by Stanford students Tony Xu , Andy Fang , and Stanley Tang , the company currently reaches 80 percent of U.S. households and has the widest selection of restaurants, cementing …

Bain Capital

Private placement grosses $65mm for Constellation | 10/3/2019

Private placement grosses $65mm for Constellation Deal Date: Oct-01-2019 / Deal 201930514 Executive Summary Constellation Pharmaceuticals Inc. (epigenetics-based cancer drug development) grossed $65mm through a private placement of 7.6mm common shares at $8.50 (a 22% premium) to Venrock Healthcare (lead), Bain Capital, Vivo Capital, BCIP, and Ponoi Capital (affiliate of The Column Group). Proceeds will support pipeline activities including work on CPI0610 (Phase II for myelofibrosis), CPI1205 (Phase II …

Andreessen Horowitz

Vice Buys Refinery29 As the Great Digital Media Consolidation Continues: Term Sheet | Fortune | 10/3/2019

… startups, raised $20 million in Series A funding. Charles River Ventures led the round, and was joined by investors including Andreessen Horowitz. – ControlRad Inc , an Atlanta-based medical tech company, raised $15 million in Series … B funding of an undisclosed amount. Investors include Lupa Systems, Venrock and Valor Equity Partners. HEALTH & LIFE SCIENCES DEALS – Tenaya Therapeutics, Inc , a San Francisco-based developer of curative therapies that target the underlying causes …

Term Sheet: Oct. 03, 2019 | 10/3/2019

… startups, raised $20 million in Series A funding. Charles River Ventures led the round, and was joined by investors including Andreessen Horowitz. - ControlRad Inc , an Atlanta-based medical tech company, raised $15 million in Series … B funding of an undisclosed amount. Investors include Lupa Systems, Venrock and Valor Equity Partners. HEALTH & LIFE SCIENCES DEALS - Tenaya Therapeutics, Inc , a San Francisco-based developer of curative therapies that target the underlying causes …

T. Rowe Price

Vice Buys Refinery29 As the Great Digital Media Consolidation Continues: Term Sheet | Fortune | 10/3/2019

T. Rowe Price Associates led the round, and was joined by investors including Salesforce Ventures . – Percipient.ai , a Sunnyvale, Calif.-based artificial intelligence, machine learning and – computer vision firm, raised Series B funding of an undisclosed amount. Investors include Lupa Systems, Venrock and Valor Equity Partners. HEALTH & LIFE SCIENCES DEALS – Tenaya Therapeutics, Inc , a San Francisco-based developer of curative therapies that target the underlying causes of heart disease, raised $92 …

Term Sheet: Oct. 03, 2019 | 10/3/2019

T. Rowe Price Associates led the round, and was joined by investors including Salesforce Ventures . - Percipient.ai , a Sunnyvale, Calif.-based artificial intelligence, machine learning and - computer vision firm, raised Series B funding of an undisclosed amount. Investors include Lupa Systems, Venrock and Valor Equity Partners. HEALTH & LIFE SCIENCES DEALS - Tenaya Therapeutics, Inc , a San Francisco-based developer of curative therapies that target the underlying causes of heart disease, raised $92 …

Vivo Capital

Private placement grosses $65mm for Constellation | 10/3/2019

Private placement grosses $65mm for Constellation Deal Date: Oct-01-2019 / Deal 201930514 Executive Summary Constellation Pharmaceuticals Inc. (epigenetics-based cancer drug development) grossed $65mm through a private placement of 7.6mm common shares at $8.50 (a 22% premium) to Venrock Healthcare (lead), Bain Capital, Vivo Capital, BCIP, and Ponoi Capital (affiliate of The Column Group). Proceeds will support pipeline activities including work on CPI0610 (Phase II for myelofibrosis), CPI1205 (Phase II …

Bain Capital Ventures

WeWork Tries to Address Investor Concerns With Big Governance Changes: Term Sheet | Fortune | 9/13/2019

… has raised more than $332 million in total venture capital funding since its inception. Its largest outside backers include Fidelity, Venrock, NEA, and Pelion Ventures. The company was last valued at $3.2 billion in the … raised $2.6 million in seed funding. Investors include Checkr and Bain Capital Ventures. – Prevu , a New York-based digital home buying platform, raised $2 million in seed funding. Corigin Ventures led the round, and was …

Account Based Orchestration Platform 6sense Raises $27 Million | 4/24/2019

Account Based Orchestration Platform 6sense Raises $27 Million 6sense, a San Francisco-based Account Based Orchestration Platform that is powered by AI, has announced it has raised $27 million in funding led by Industry Ventures. Existing investors Bain Capital Ventures, Battery Ventures, Costanoa Ventures, Salesforce Ventures, and Venrock also participated in this round. “We believe AI insights and orchestration are the future of B2B sales and marketing. I’m humbled by …

Union Square Ventures

WeWork Tries to Address Investor Concerns With Big Governance Changes: Term Sheet | Fortune | 9/13/2019

… has raised more than $332 million in total venture capital funding since its inception. Its largest outside backers include Fidelity, Venrock, NEA, and Pelion Ventures. The company was last valued at $3.2 billion in the … Horowitz, Accomplice, AppWorks, Autonomous Partners, Fenbushi Digital, Warner Music Group , Union Square Ventures, Venrock, Digital Currency Group, Animoca Brands, SV Angel, Version One, and CoinFund . – Rafay Systems , a Sunnyvale, Calif.-based platform which allows companies …

Exclusive: From CryptoKitties to Cardi B: Warner Music Joins $11 Million Investment In Ethereum Replacement | Forbes | 9/12/2019

… Union Square Ventures, Venrock and others, Bronikowski says Warner Music’s blockchain team will work with Dapper Labs to create digital assets using a new public blockchain revealed today, called Flow, that is capable of handling transaction volumes many times more than ethereum, even while expanding on a number of the company’s other blockchain projects. At stake is not only the success of Dapper Labs itself, but the pole position in …

Salesforce Ventures

Secretive Defense Tech Startup Anduril Reaches Unicorn Status: Term Sheet | Fortune | 9/12/2019

… industry of supply chain and logistics management. He and co-founder Andrea Aranguren have raised $10 million in funding from Venrock and Rucker Park. This is O’Kelley’s third startup. Before AppNexus, he sold his first … round, and was joined by investors including Alven, Partech, and Salesforce Ventures . – Lacework , a Mountain View, Calif.-based security platform for enterprise innovation, raised $42 million in funding. Investors include Sutter Hill Ventures and Liberty …

Sprout, The Company Focused on Women’s Sexual Pleasure, Raises $20 Million: Term Sheet | Fortune | 9/4/2019

… solutions, raised $14 million as an extension of its previous Series C funding round. Investors include Deutsche Telekom Capital Partners, Salesforce Ventures, Scale Venture Partners, Adam Street Partners, Canaan Partners, Vertex Ventures and Data Collective … billion and earnings of $237.7 million in 2018. Foresite Capital, Venrock, Paladin Capital , and Fidelity back the firm. It plans to list on the NYSE as “NVST.” Read more . – Vir Biotechnology , a San Francisco-based …

Founders Fund

Secretive Defense Tech Startup Anduril Reaches Unicorn Status: Term Sheet | Fortune | 9/12/2019

Anduril, the secretive defense tech startup co-founded by Oculus founder Palmer Luckey and Founders Fund partner Trae Stephens, has raised new funding at a valuation of more than $1 billion, according to CNBC. Andreessen … founder Andrea Aranguren have raised $10 million in funding from Venrock and Rucker Park. This is O’Kelley’s third startup. Before AppNexus, he sold his first company Right Media for $680 million to Yahoo in 2007 …

HCA

Iris Dorbian wrote a new post, Oxford Finance provides $60 mln to VC-backed RefleXion Medical, on the site PE Hub | 5/1/2019

Oxford Finance provides $60 mln to VC-backed RefleXion Medical May 1, 2019 Print Email Oxford Finance LLC has provided a $60 million loan to Hayward, California-based RefleXion Medical Inc , a biotargeting oncology company. Armentum Partners served as financial adviser to RefleXion Medical on the financing. RefleXion is backed by TPG Growth/The Rise Fund, Sofinnova Partners, KCK Group, Venrock, T. Rowe Price Associates, Inc, GT Healthcare Capital Partners …

75% of healthcare experts struggle with implementing blockchain | Becker’s Hospital Review | 4/18/2019

75% of healthcare experts struggle with implementing blockchain Mackenzie Garrity - Print Email Venrock released its 2019 Healthcare Prognosis report, which included insights on the progress of artificial intelligence and blockchain within the industry. In 2019, blockchain in healthcare may not exist, Venrock found. The report showed that 75 percent of industry experts are struggling to find blockchain’s role in healthcare. Another 18 percent are finding use cases that benefit patients …

Matt Eakins

Leading Women’s Health Care Company Partners with Suki to Offer Digital Voice Assistant for its Physicians | PR Newswire | 6/11/2019

… incredibly personal, and Suki helps providers to concentrate on providing exceptional care by lowering the barrier created by EHRs,” said Matt Eakins , MD, Chief Operating Officer at Unified. “Suki not only helps our providers more … Redwood City, Calif. , Suki is backed by investors such as Venrock, First Round, Social Capital, and Marc Benioff . To learn more, visit suki.ai , or follow them on AngelList , Facebook , LinkedIn , and Twitter . About Unified Physician …

Kirk Falconer

Kirk Falconer wrote a new post, Venture-backed Milestone prices Nasdaq IPO to raise $111 mln, on the site PE Hub | 5/9/2019

… 105 million raised last year , led by RTW Investments and joined by BDC Capital , Domain Associates , Fonds de solidarité FTQ , Forbion , GO Capital , Novo Holdings , Pappas Capital , Tavistock Group , Tekla Capital Management and Venrock . PRESS RELEASE Milestone Pharmaceuticals Announces Pricing of Upsized Initial Public Offering MONTREAL and CHARLOTTE, N.C., May 8, 2019 /CNW/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing …

Kirk Falconer wrote a new post, Biolux Research closes $14 mln Series A round led by Venrock, on the site PE Hub | 4/30/2019

Biolux Research closes $14 mln Series A round led by Venrock April 30, 2019 Print Email Photo courtesy of Product Creation Studio Biolux Research , a Vancouver-based developer of light-accelerated orthodontic products, has raised $14 million in a Series A financing. The round was led by Venrock , a U.S. technology and healthcare venture capital firm. It was joined by Correlation Ventures and other investors. Founded in 2007, Biolux is …

Christopher A. Herr

Oxford Finance Closes $60 Million Credit Facility with Oncology Innovator RefleXion Medical | PR Newswire | 5/1/2019

… and in the same session, while minimizing the impact on healthy tissue surrounding each tumor, has not been available,” said Christopher A. Herr , senior managing director at Oxford. “RefleXion’s biology-guided radiotherapy is designed to … firms TPG Growth/The Rise Fund, Sofinnova Partners, KCK Group, Venrock, T. Rowe Price Associates, Inc., China -focused healthcare investment firm GT Healthcare Capital Partners, and global pharmaceutical leaders Pfizer Venture Investments and Johnson & Johnson …

Iris Dorbian wrote a new post, Oxford Finance provides $60 mln to VC-backed RefleXion Medical, on the site PE Hub | 5/1/2019

… adviser to RefleXion Medical on the financing. RefleXion is backed by TPG Growth/The Rise Fund, Sofinnova Partners, KCK Group, Venrock, T. Rowe Price Associates, Inc, GT Healthcare Capital Partners, Pfizer Venture Investments and Johnson … healthy tissue surrounding each tumor, has not been available,” said Christopher A. Herr, senior managing director at Oxford. “RefleXion’s biology-guided radiotherapy is designed to provide just that, localization of multiple tumors and radiotherapy delivered …

David Thrower

Biolux Research Raises $14M in Series A Round led by Venrock; Appoints David Thrower as Chief Executive Officer | 4/30/2019

30/04/2019 Biolux Research announced the close of a $14M Series A round led by Venrock and joined by Correlation Ventures, insiders and other investors. Coincident with the completion of the round, Biolux announced that David Thrower has been appointed Chief Executive Officer of the company. Biolux manufactures OrthoPulse, an FDA cleared orthodontic device currently being sold in the United States, Europe, and Asia. OrthoPulse is a non-invasive technology which …

Kirk Falconer wrote a new post, Biolux Research closes $14 mln Series A round led by Venrock, on the site PE Hub | 4/30/2019

Biolux Research closes $14 mln Series A round led by Venrock April 30, 2019 Print Email Photo courtesy of Product Creation Studio Biolux Research , a Vancouver-based developer of light-accelerated orthodontic products, has raised … Europe and Asia. The company also announced the appointment of David Thrower , a medical device industry executive, as its new CEO. PRESS RELEASE Biolux Research Raises $14M in Series A Round led by Venrock; Appoints …

Jason Zintak

6sense raises $27 million for its marketing and sales predictive analytics tool | VentureBeat | 4/16/2019

Venrock also participating. 6sense, which described the new round as “growth funding following series B,” has raised $63 million to date. 6sense CEO Jason Zintak said the five-year-old startup, which last year doubled its headcount and expanded its offices in New York and India, will use the fresh capital to expand its product offering and acquire new clients. “The funding will allow 6sense to expand its product, including …

6sense Secures $27 Million to Advance Bold Vision in B2B and ABM | Business Wire | 4/16/2019

Venrock . “We believe AI insights and orchestration are the future of B2B sales and marketing. I’m humbled by the overwhelming support from our customers and team as we execute on our bold vision,” said Jason Zintak, CEO of 6sense. “This new round of funding will allow us to expand our product, including transforming the traditional email nurture track into multi-channel next-best-action suggestions that adjust in real-time …

Ken Wallace

6sense Secures $27 Million to Advance Bold Vision in B2B and ABM | Business Wire | 4/16/2019

… led by Industry Ventures and included participation from existing investors Bain Capital Ventures , Battery Ventures , Costanoa Ventures , Salesforce Ventures , and Venrock . “We believe AI insights and orchestration are the future of B2B sales and marketing … sales teams need to identify and close new business,” said Ken Wallace of Industry Ventures, a leading investment firm with over $3.4 billion of institutional capital. “We believe 6sense’s unmatched ability to uncover previously unknown …

Jason Purcell

Walmart Product Page Analysis Now Offered in Salsify’s Complimentary Product Content Grader | PR Newswire | 12/8/2017

… manufacturers. “More than ever, brands need to understand the impact their product page has on their entire marketing funnel,” said Jason Purcell, co-founder and CEO at Salsify. “The latest version of Salsify’s Content Grader … a total of $54.6 million in funding, led by Underscore.VC, Venrock, Matrix Partners and North Bridge. For more information, please visit: http://www.salsify.com . Media Contact …

Walmart Product Page Analysis Now Offered in Salsify’s Complimentary Product Content Grader | PR Newswire | 12/8/2017

… manufacturers. “More than ever, brands need to understand the impact their product page has on their entire marketing funnel,” said Jason Purcell, co-founder and CEO at Salsify. “The latest version of Salsify’s Content Grader … a total of $54.6 million in funding, led by Underscore.VC, Venrock, Matrix Partners and North Bridge. For more information, please visit: http://www.salsify.com . Media Contact Peter Crosby Salsify [email protected] View original content with multimedia …

Gerrit Klaerner

Tricida Announces Closing of $57.5 Million Series D Financing | Morningstar | 11/8/2017

… 57.5 million Series D financing, bringing the company’s total capital raised to-date to $153.3 million. Wellington Management Company LLP, Venrock Healthcare Capital Partners and Cormorant Asset Management joined existing investors OrbiMed, Longitude Capital, Sibling … suffering from metabolic acidosis associated with chronic kidney disease,” said Gerrit Klaerner, Ph.D., Chief Executive Officer of Tricida. “We are exceptionally pleased to have completed this financing with a majority of the capital coming from …

Tricida Announces Closing of $57.5 Million Series D Financing | Business Wire | 11/8/2017

… 57.5 million Series D financing, bringing the company’s total capital raised to-date to $153.3 million. Wellington Management Company LLP, Venrock Healthcare Capital Partners and Cormorant Asset Management joined existing investors OrbiMed, Longitude Capital, Sibling … suffering from metabolic acidosis associated with chronic kidney disease,” said Gerrit Klaerner, Ph.D., Chief Executive Officer of Tricida. “We are exceptionally pleased to have completed this financing with a majority of the capital coming from …